Cancer Research

MicroRNA Markers Linked to Cancer Muscle Wasting in Dogs
Research & Development MicroRNA Markers Linked to Cancer Muscle Wasting in Dogs

Introduction Recent veterinary breakthroughs suggest that the silent deterioration of muscle mass in aging canines might finally have a detectable genetic signature that identifies early signs of physical decline. This syndrome, known as cachexia, often acts as a shadow to malignant tumors,

Can AI and Endoscopy Transform Photothermal Cancer Therapy?
Research & Development Can AI and Endoscopy Transform Photothermal Cancer Therapy?

The landscape of modern oncology is undergoing a dramatic transformation as clinicians and researchers move away from the systemic toxicity of traditional chemotherapy toward highly localized, minimally invasive interventions. Photothermal therapy represents one of the most promising frontiers in

Lung Cancer Shows Major Sex-Based Protein Differences
Research & Development Lung Cancer Shows Major Sex-Based Protein Differences

The landscape of modern oncology is currently undergoing a transformative shift toward a more granular understanding of how individual biological factors influence disease pathology and treatment outcomes. For years, medical research often operated under a generalized framework, but recent evidence

How Will the Dark Genome Transform Personalized Oncology?
Tech & Innovation How Will the Dark Genome Transform Personalized Oncology?

Scientists have spent decades meticulously mapping the two percent of the human genome that codes for proteins, yet the remaining ninety-eight percent, often dismissed as "junk DNA," is proving to be the most critical frontier in modern oncology. This vast, unexplored territory, now commonly

South Korea Unveils Advanced Regenerative Medicine Plan
Research & Development South Korea Unveils Advanced Regenerative Medicine Plan

The South Korean government has officially introduced a bold strategic roadmap to transform its medical sector through the 2nd Basic Plan for Advanced Regenerative Medicine and Advanced Biopharmaceuticals. This five-year initiative, spanning the period from 2026 to 2030, aims to establish a

Breakthrough DNA-Based Immunotherapy Targets Ovarian Cancer
Research & Development Breakthrough DNA-Based Immunotherapy Targets Ovarian Cancer

Ovarian cancer remains one of the most formidable challenges in modern oncology due to its tendency to be diagnosed at advanced stages when traditional treatments often prove insufficient for long-term survival. For decades, the standard of care has relied heavily on aggressive surgery and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later